Table 1.
Percentage of methylated CpG in various normal and tumor cell lines. Sequence analysis was performed after bisulfite treatment.
Cells | Tumor type | meth CpG |
CCL-75 | Fibroblast | 5% |
NHBE | Normal | 6.3% |
SAEC | Normal | 4.5% |
A460 | Large cell | 7.9% |
H838 | Adenocarcinoma | 8.2% |
H1703 | Squamous cell | 6.6% |
A549 | Adenocarcinoma | 5.1% |
MS1 | Mesothelioma | 2.2% |
H290 | Mesothelioma | 4% |
MCF-7 | Breast cancer | 1.6% |
BT474 | Breast cancer | 2% |